NXL
Nexalin Technology, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$2.36
+0.43%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 8.45x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.63x
- Price / sales
- 11.40x
- Price / cash flow
- -0.40x
Enterprise value
- Enterprise value
- $1.5M
- EV / sales
- 6.77x
- EV / EBITDA
- -0.16x
- EV / EBIT
- -0.16x
- Market cap
- $2.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026